Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III. Result of a randomized multicenter trial (BETACAR Trial)

International Journal of Cardiology

Volumn 113, Issue 2, 2006, Pages 153-160

  Figulla, Hans R ^a   Krzeminska Pakula, Maria ^b   Wrabec, Krzystof ^c   Chochola, Jiri ^d   Kalmbach, Claudia ^a   Fridl, P ^e  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Klinika Kardiologii   (Poland)

^c Oddzial Szpitola   (Poland)

^d Internal Department   (Czech Republic)

^e INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

blockers; Betaxolol; Carvedilol; Heart failure; Metoprolol

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CARVEDILOL; PLACEBO;

ADULT; ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG HALF LIFE; DRUG POTENCY; DRUG SELECTIVITY; EXERCISE TEST; FEMALE; HEART BUNDLE BRANCH BLOCK; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITALIZATION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WALKING;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BETAXOLOL; CARBAZOLES; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME;

EID: 33750490097     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.06.067     Document Type: Article

References (11)

1. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 (1997) 1349-1353
2. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Remme W.J., and Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22 (2001) 1527-1560
3. Remme W.J. Should ACE inhibition always be first-line therapy in heart failure? Lessons from the CARMEN Study. Cardiovasc Drugs Ther 17 (2003) 107-109
4. Poole-Wilson P.A., Swedberg K., Cleland J.G.F., et al. For the COMET investigators, comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol Or metoprolol European trial (COMET): randomised controlled trial. Lancet 362 (2003) 7-13
5. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353 (1999) 2001-2007
6. Lechat P., Hulot J.-S., Escolano S., et al. Heart rate and cardiac rhythm relationships with bisoprolol. Benefit in chronic heart failure in CIBIS II trial. Circulation 103 (2001) 1428-1433
7. Lechat P., Escolano S., Golmard J.L., et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the cardiac insufficiency bisoprolol study (CIBIS). Circulation 96 (1997) 2197-2205
8. Bianchetti B., et al. Pharmacokinetics of the new β1-adrenorezeptor blocking agent betaxolol (SL 75212) in man after repeated oral administration. Drug Res 30 (1980) 1912
9. Böhler S., Saubadu S., Scheldewaert R., and Figulla H.R. Betaxolol versus carvedilol in chronic heart failure (BETACAR study). Rationale and design. Drug Res 49 (1999) 311-317
10. Sanderson J.E., Chan S.K.W., Yip G., et al. Beta-blockade in heart failure. A comparison of carvedilol with metoprolol. J Am Coll Cardiol 34 (1999) 1522-1528
11. Metra M., Giubbini R., Nodari S., et al. Differential effects of β-blockers in patients with heart failure. A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation 102 (2000) 546-551